Heidy King-Jones sold $2.6M of Spyre Therapeutics, Inc. (SYRE) stock

Heidy King-Jones sold 28,933 shares of SYRE stock worth $2.6M, per an SEC Form 4 filed Oct 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 1, 2026, 2 days before it was made public.

SYRE has moved +3.6% since the trade date, from $89.93 to $93.19 (Oct 2, 2026 close).